CD168 in lung adenocarcinoma: prognostic relevance, immune feature associations, and MAPK/ERK pathway enrichment
Fields of Study & Subjects
Lung Cancer Research Studies
Cancer-related molecular mechanisms research
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Medical Oncology
- Volume
- 43
- Issue
- 3
- Pages
- 140–140
- Publication date
- 6 February 2026
- Language
- EN